Seemed a bit of a fizzer. Jeez I hope MPL fairs better.
Some points I took from the conclusion statements.
1. No observation of disease slowing using the scale. Not good...
2. We cross the BBB. Seems rapamycin doesnt...is this the key?
Fingers crossed. Hopefully we are not let down after all the build up.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-162
-
- There are more pages in this discussion • 1,263 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.22M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $244.3K | 1.244M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 257206 | 7 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |